Saturday, May 19, 2018

Osteoporosis Drug Shows Cardioprotective Potential at 10-Year Follow-Up

The 1-year cardiovascular mortality hazard ratio (HR) for alendronate users was 0.33 (95% CI, 0.17 to 0.65) and 0.55 for incident myocardial infarction (95% CI, 0.34 to 0.89).
Osteoporosis Drug Shows Cardioprotective Potential at 10-Year Follow-Up posted first on https://www.youtube.com/dailyhealthpost/

No comments:

Post a Comment